Ghana sheep pneumonia study highlights pathogen mix and drug resistance: full analysis

A newly published study in Frontiers in Veterinary Science points to Mannheimia haemolytica as the dominant bacterial finding in pneumonic sheep lungs sampled at two Ghanaian abattoirs, while also documenting notable resistance to several commonly used antimicrobials. Among 75 pneumonic lungs cultured from sheep at Tamale and Kumasi, M. haemolytica was isolated from 54.7% of samples, ahead of Staphylococcus aureus, E. coli, Klebsiella spp., and P. multocida. Susceptibility testing showed the main Pasteurellaceae isolates were most responsive in vitro to cefotaxime and ciprofloxacin, but less so to amoxicillin, doxycycline, and penicillin G. (frontiersin.org)

The work builds on earlier Ghanaian pathology research from the same group and adds a piece that’s often missing in small-ruminant respiratory disease reports: antimicrobial susceptibility tied to postmortem lung findings. That matters because ovine respiratory disease is rarely a single-agent problem. Recent Frontiers background on lamb respiratory disease describes it as multifactorial, with stress, host factors, environmental conditions, and coinfections all shaping disease expression, while secondary bacterial invaders can include M. haemolytica, P. multocida, Staphylococcus spp., and Pseudomonas spp. (frontiersin.org)

In the Ghana study, M. haemolytica was particularly linked with broncho-interstitial pneumonia and interstitial pneumonia, while P. multocida was more prominent in interstitial cases. The isolates were collected from condemned pneumonic lungs, and susceptibility testing used the Kirby-Bauer disk diffusion method in line with CLSI veterinary standards. The authors reported that M. haemolytica and P. multocida were highly susceptible to cefotaxime, at 95% and 100%, respectively, and also showed relatively strong susceptibility to ciprofloxacin, at 83% and 91%. By contrast, resistance was substantial for amoxicillin, at 66% and 78%, doxycycline, at 76% and 74%, and penicillin G, with P. multocida resistance at 52%. Seasonal signals also emerged, with M. haemolytica and P. multocida more common in the dry season. (frontiersin.org)

The paper also broadens the picture beyond Pasteurellaceae. S. aureus showed good susceptibility to gentamicin, but resistance to tetracycline, while Pseudomonas spp. were fully susceptible to gentamicin, meropenem, and amikacin in this dataset. Klebsiella spp., E. coli, and Citrobacter spp. were reported as highly susceptible to ciprofloxacin, gentamicin, ceftriaxone, and amikacin, but resistant to tetracycline. The authors explicitly connect those findings to food-chain risk, arguing that resistant organisms recovered from sheep lungs at slaughter could contribute to carcass contamination and wider AMR spread if hygiene and antimicrobial oversight are weak. (frontiersin.org)

There doesn’t appear to be a separate institutional press release or outside quote tied directly to this paper yet, but the study’s interpretation lines up with broader expert guidance. WOAH’s standards on responsible and prudent antimicrobial use in veterinary medicine emphasize that veterinarians should consider antimicrobial importance rankings and use these drugs judiciously as part of a One Health approach. FAO and published One Health reviews focused on Ghana likewise describe AMR as an interconnected animal, human, food-chain, and environmental issue, which supports the authors’ concern that abattoir findings shouldn’t be viewed only as a flock-health problem. (woah.org)

Why it matters: For veterinary professionals, the practical takeaway isn’t simply that cefotaxime or ciprofloxacin looked strong in vitro. It’s that local bacteriology and susceptibility patterns matter, especially in small-ruminant systems where treatment may still lean on older, more available drugs. At the same time, the very drugs that performed best here include classes that stewardship frameworks treat cautiously because of their importance in both animal and human health. That tension is central to the paper: better targeting of therapy is needed, but so is restraint, culture-based decision-making, and stronger surveillance. (frontiersin.org)

The study also has limits that should temper how far clinicians extrapolate. It was cross-sectional, abattoir-based, and relatively small, which means it can’t establish causality or represent all sheep populations in Ghana. The authors note possible misclassification of lesion types, sparse-table statistical issues, incomplete quality-control measures for susceptibility testing, and the absence of molecular confirmation such as PCR or sequencing for species identification. In other words, this is useful field intelligence, not the last word on ovine pneumonia epidemiology in West Africa. (frontiersin.org)

What to watch: The next important step will be larger flock-level surveillance studies that combine pathology, culture, and molecular diagnostics, and that follow resistance trends over time rather than at slaughter alone. If those studies confirm the same susceptibility pattern, they could inform more region-specific treatment guidance for sheep pneumonia in Ghana while also feeding into broader One Health AMR monitoring. (frontiersin.org)